RKLB
Rocket Lab USA, Inc.
RKLB has the edge over TRNS overall, supported by stronger valuation and stronger fundamentals.
TRNS
Transcat, Inc.
TRNS has lower modeled downside risk, despite its lower overall score.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
TRNS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Stable |
TRNS's revenue is currently healthy, and its profitability, cash flow and balance sheet are stable.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
TRNS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 38x | $17.80 | -83% |
| Forward | 47x | $106 | — |
| Fair | 54x | $25.31 | -76% |
| Expensive | 83x | $39.15 | -63% |
| Current | 226x | $106 | — |
Historical ranges are pointers, not guarantees.
TRNS's PE is in its expensive range at 226x. If earnings grow as analysts expect, today's price would be 47x next year's earnings, in its cheap range.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TRNS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TRNS, with profitability improving. However, they disagree widely on these estimates.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
TRNS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.27 | +383% |
| Q3 2026 | $0.47 | -62% |
| Q2 2026 | $0.36 | -75% |
| Q1 2026 | $0.57 | -64% |
| Q4 2025 | $0.86 | -54% |
| Q3 2025 | $1.23 | -39% |
| Q2 2025 | $1.44 | -17% |
| Q1 2025 | $1.57 | -3.7% |
| Q4 2024 | $1.89 | +45% |
TRNS has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over TRNS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
TRNS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $97.1M | +18% |
| Q2 2026 | $92.9M | +22% |
| Q1 2026 | $89.3M | +16% |
| Q4 2025 | $83.9M | +26% |
| Q3 2025 | $82.3M | +21% |
| Q2 2025 | $76.4M | +15% |
| Q1 2025 | $77.1M | +8.8% |
| Q4 2024 | $66.8M | +2.4% |
TRNS's revenue has grown year over year every quarter since late 2020: $97M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.2% | +0.9 points |
| Q2 2026 | 4% | -3 points |
| Q1 2026 | 4.8% | -4.2 points |
| Q4 2025 | 0.1% | -3 points |
| Q3 2025 | 4.3% | -1.3 points |
| Q2 2025 | 7% | -0.7 points |
| Q1 2025 | 9% | -4 points |
| Q4 2024 | 3.1% | -3.4 points |
TRNS has the edge over RKLB on profitability, with a higher operating margin.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
TRNS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.1M | -28% |
| Q2 2026 | $4.8M | +$5.8M |
| Q1 2026 | $2.6M | -67% |
| Q4 2025 | $9.5M | -2.7% |
| Q3 2025 | $8.4M | +194% |
| Q2 2025 | -$975K | -119% |
| Q1 2025 | $7.9M | +413% |
| Q4 2024 | $9.7M | +34% |
TRNS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
TRNS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +74K shares |
| 1 year | +1.6% | +148K shares |
| 3 years | +20% | +1.6M shares |
| 5 years | +26% | +2M shares |
| Available history | +26% | +2M shares |
TRNS has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1.9M |
| Q1 2026 | $372,000 |
| Q4 2025 | $13,000 |
| Q3 2025 | $110,000 |
| Q2 2025 | — |
| Q1 2025 | $357,000 |
| Q4 2024 | $182,000 |
| Q3 2024 | $1.4M |
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TRNS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 2.4x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 1.0x | Healthy |
TRNS's net debt is about 2.7 years of its operating earnings (EBITDA), about the same as a year ago.
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
TRNS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.7 | Neutral |
| Stochastic | 62.5 | Neutral |
TRNS's weekly RSI is 69 (neutral) and its Stochastic is 62 (neutral).
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
TRNS PE vs Industrials Sector
| Metric | TRNS | Sector median | Relative |
|---|---|---|---|
| PE | 226x | 24x | 840% above |
| PE % | 97 | 58 | 39 pts above |
TRNS is trading at 226x earnings, a 840% premium to the Industrials sector's median of 24x.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
TRNS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $90.1 | 18% above |
| 20 week MA | $88.9 | 20% above |
| 50 week MA | $79.4 | 34% above |
| 100 week MA | $79.9 | 33% above |
| 200 week MA | $91.5 | 16% above |
TRNS has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.
TRNS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.8 | $33.0 | +3.8% |
| 2021 | $33.0 | $92.9 | +181% |
| 2022 | $92.9 | $70.0 | -25% |
| 2023 | $70.0 | $109.3 | +56% |
| 2024 | $109.3 | $106.0 | -3% |
| 2025 | $106.0 | $58.9 | -44% |
| 2026 YTD | $58.9 | $106.3 | +81% |
TRNS has the edge over RKLB on returns for 2026, with the stronger performance.